We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+5.32%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
AUM
$566M
AUM Growth
+$26.3M
Cap. Flow
+$4.1M
Cap. Flow %
0.72%
Top 10 Hldgs %
31.8%
Holding
320
New
24
Increased
113
Reduced
145
Closed
15

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$3.18M
2
AZN icon
AstraZeneca
AZN
+$3.16M
3
LUMN icon
Lumen
LUMN
+$2.71M
4
PPL
PPL Corp
PPL
+$2.54M
5
KMB icon
Kimberly-Clark
KMB
+$2.52M

Sector Composition

Rank Sector Weight
1 Financials 12.56%
2 Industrials 11.86%
3 Healthcare 9.46%
4 Technology 7.68%
5 Consumer Discretionary 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DON icon
251
WisdomTree US MidCap Dividend Fund
DON
$4.05B
$304K 0.05%
9,651
-684
-7% -$20.9K
CCI icon
252
Crown Castle
CCI
$32.4B
$302K 0.05%
3,485
-836
-19% -$73.2K
AFL icon
253
Aflac
AFL
$64.4B
$300K 0.05%
8,612
-110
-1% -$3.87K
IJS icon
254
iShares S&P Small-Cap 600 Value ETF
IJS
$8.14B
$298K 0.05%
4,256
MA icon
255
Mastercard
MA
$487B
$293K 0.05%
2,839
-2,450
-46% -$254K
NEA icon
256
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.35B
$292K 0.05%
21,901
-1,936
-8% -$26.2K
UPS icon
257
United Parcel Service
UPS
$96B
$292K 0.05%
2,543
-2,237
-47% -$252K
FAST icon
258
Fastenal
FAST
$54.7B
$288K 0.05%
24,520
+1,516
+7% +$16.6K
FCX icon
259
Freeport-McMoran
FCX
$90.2B
$286K 0.05%
+21,688
New +$277K
NEU icon
260
NewMarket
NEU
$7.13B
$286K 0.05%
675
-12
-2% -$4.95K
IBB icon
261
iShares Biotechnology ETF
IBB
$9.44B
$283K 0.05%
3,198
-300
-9% -$27.3K
ESRX
262
DELISTED
Express Scripts Holding Company
ESRX
$274K 0.05%
3,979
+446
+13% +$32K
VOO icon
263
Vanguard S&P 500 ETF
VOO
$968B
$271K 0.05%
1,320
-1,000
-43% -$201K
CSQ icon
264
Calamos Strategic Total Return Fund
CSQ
$3.21B
$268K 0.05%
26,079
-5,323
-17% -$53.7K
FTV icon
265
Fortive
FTV
$19.2B
$268K 0.05%
7,910
+3
+0% +$99
DUK icon
266
Duke Energy
DUK
$100B
$267K 0.05%
3,439
-540
-14% -$41.4K
CRM icon
267
Salesforce
CRM
$142B
$266K 0.05%
3,882
-600
-13% -$43.5K
STJ
268
DELISTED
St Jude Medical
STJ
$266K 0.05%
3,317
+140
+4% +$11.1K
BIIB icon
269
Biogen
BIIB
$29.5B
$260K 0.05%
+917
New +$272K
OKS
270
DELISTED
Oneok Partners LP
OKS
$260K 0.05%
6,042
NFJ
271
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.41B
$259K 0.05%
20,551
-3,327
-14% -$41.6K
TMO icon
272
Thermo Fisher Scientific
TMO
$208B
$257K 0.05%
1,822
-396
-18% -$58.4K
MRO
273
DELISTED
Marathon Oil Corporation
MRO
$255K 0.05%
14,707
-732
-5% -$11.8K
ISRG icon
274
Intuitive Surgical
ISRG
$128B
$251K 0.04%
3,564
+27
+0.8% +$1.99K
MU icon
275
Micron Technology
MU
$1.02T
$246K 0.04%
11,232
-108
-1% -$2.03K

Similar funds

Corient Capital Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Corient Capital Partners held 320 positions worth $566M, up 4.9% from $540M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Corient Capital Partners's Q4 2016 filing shows 24 new, 113 increased, 145 reduced and 15 closed positions. Its largest new stake was State Street Consumer Staples Select Sector SPDR ETF: 121,417 shares worth $6.28M. The largest sale was Eli Lilly, an estimated $3.18M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 11% a quarter earlier, followed by Industrials and Healthcare.

  • Corient Capital Partners's largest Q4 2016 buy was State Street Consumer Staples Select Sector SPDR ETF: 121,417 shares worth $6.28M.
  • Corient Capital Partners added most to State Street Health Care Select Sector SPDR ETF in Q4 2016, an estimated $6.76M increase.
  • Corient Capital Partners's biggest Q4 2016 reduction was Eli Lilly, cutting an estimated $3.18M.
  • Corient Capital Partners fully exited Macy's in Q4 2016, selling an estimated $1.89M.
  • Corient Capital Partners's ten largest holdings make up 32% of its $566M portfolio in Q4 2016.
  • Corient Capital Partners opened 24 new positions and closed 15 in Q4 2016.
  • Corient Capital Partners's portfolio value rose 4.9% quarter-over-quarter to $566M.

Based on Corient Capital Partners's 13F filing for Q4 2016, filed 10 Feb 2017.